Search Results (65)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Exploring Health Disparities: Comparing Individuals with Intellectual and Developmental Disabilities and the General Population in Missouri | Grant |
Why?
|
| Long-Term Aripiprazole in Youth With Developmental Disabilities Including Autism. | Academic Article |
Why?
|
| Developmental Disabilities | Concept |
Why?
|
| Comparison of energy intake assessed by image-assisted food records to doubly labelled water in adolescents with intellectual and developmental disabilities: a feasibility study. | Academic Article |
Why?
|
| Weight status and associated comorbidities in children and adults with Down syndrome, autism spectrum disorder and intellectual and developmental disabilities. | Academic Article |
Why?
|
| Nadler, Cy | Person |
Why?
|
| Changes in physical activity across a 6-month weight loss intervention in adolescents with intellectual and developmental disabilities. | Academic Article |
Why?
|
| Intrapersonal, interpersonal and environmental correlates of moderate to vigorous physical activity and sedentary time in adolescents with intellectual and developmental disabilities. | Academic Article |
Why?
|
| 1.39 Mb inherited interstitial deletion in 12p13.33 associated with developmental delay. | Academic Article |
Why?
|
| 15q11.2 proximal imbalances associated with a diverse array of neuropsychiatric disorders and mild dysmorphic features. | Academic Article |
Why?
|
| A 15q13.3 homozygous microdeletion associated with a severe neurodevelopmental disorder suggests putative functions of the TRPM1, CHRNA7, and other homozygously deleted genes. | Academic Article |
Why?
|
| A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndrome. | Academic Article |
Why?
|
| Current advances in chronic kidney disease in children: growth, cardiovascular, and neurocognitive risk factors. | Academic Article |
Why?
|
| De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation. | Academic Article |
Why?
|
| De novo frameshift mutation in ASXL3 in a patient with global developmental delay, microcephaly, and craniofacial anomalies. | Academic Article |
Why?
|